Toxin-induced models of Parkinson’s disease

By J. Bové, Delphine Prou, C. Perier, S. Przedborski. NeuroRx, 2005

648 citations recorded by the source corpus.

Subfields: Cellular and Molecular Neuroscience, Neurology

View Paper: https://www.semanticscholar.org/paper/fbf8175ad670e5d77acf45bcb2cb124c9fdc8115

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Víctor M. Víctor
2. P. Venditti
3. Tanea T Reed
4. S. Di Meo

Citations in the corpus

• Genetic Animal Models of Parkinson’s Disease (2010, neutral): “Several excellent reviews on these animal and cellular models exist (see Bové et al., 2005; Chesselet et al., 2008; Gupta et al., 2008; Lim and Ng, 2009; Moore et al., 2005; Pallanck and Whitworth, 2007; Wong, 2007).”
• Role of ROS and RNS Sources in Physiological and Pathological Conditions (2016, background): “The neurotoxin 6-hydroxydopamine (6-OHDA) is also capable of inducing Parkinson’s-like symptoms, and its use in animal models of PD predates the discovery of MPTP’s neurotoxic properties [524].”